Shenzhen Sunze Technology Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Sunze Technology Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SEHLINMEI. The owner is based in Shenzhen.

City Panorama, Xin'an St., Bao'an

Rm.1705, Bldg. G, Block E, F, G, Hualian

Shenzhen 518100 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SEHLINMEI
SEHLINMEI
Registered 2024

Trademark Classifications

Shenzhen Sunze Technology Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Sunze Technology Trading Co., Ltd. have?

Shenzhen Sunze Technology Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Sunze Technology Trading Co., Ltd. file in?

Shenzhen Sunze Technology Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Sunze Technology Trading Co., Ltd.'s most well-known trademarks?

Shenzhen Sunze Technology Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as SEHLINMEI. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Sunze Technology Trading Co., Ltd.'s trademark registration success rate?

Shenzhen Sunze Technology Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.